These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28641506)
21. MicroPET/SPECT/CT imaging of small animal models of disease. Koba W; Jelicks LA; Fine EJ Am J Pathol; 2013 Feb; 182(2):319-24. PubMed ID: 23219729 [TBL] [Abstract][Full Text] [Related]
22. Biomedical imaging in the safety evaluation of new drugs. Wang YX; Yan SX Lab Anim; 2008 Oct; 42(4):433-41. PubMed ID: 18782821 [TBL] [Abstract][Full Text] [Related]
23. [The role of advanced cardiac imaging methods in coronary artery disease]. Kiraç S Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors. Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399 [TBL] [Abstract][Full Text] [Related]
26. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367 [TBL] [Abstract][Full Text] [Related]
27. Compact Magnetic Resonance Imaging Systems-Novel Cost-Effective Tools for Preclinical Drug Safety and Efficacy Evaluation. Ramot Y; Schiffenbauer YS; Maronpot R; Nyska A Toxicol Sci; 2017 May; 157(1):3-7. PubMed ID: 28329801 [TBL] [Abstract][Full Text] [Related]
28. Anatomic pathology data generation in preclinical toxicology evaluation: Troubleshooting and risk management for toxicologists. Neef N; McInnes E Toxicol Lett; 2019 Oct; 314():164-171. PubMed ID: 31330168 [TBL] [Abstract][Full Text] [Related]
29. Deep Learning Approaches and Applications in Toxicologic Histopathology: Current Status and Future Perspectives. Mehrvar S; Himmel LE; Babburi P; Goldberg AL; Guffroy M; Janardhan K; Krempley AL; Bawa B J Pathol Inform; 2021; 12():42. PubMed ID: 34881097 [TBL] [Abstract][Full Text] [Related]
30. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities. Maronpot RR Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943 [TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects. Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699 [TBL] [Abstract][Full Text] [Related]
32. Matrix-assisted laser desorption ionization imaging mass spectrometry detection of a magnetic resonance imaging contrast agent in mouse liver. Acquadro E; Cabella C; Ghiani S; Miragoli L; Bucci EM; Corpillo D Anal Chem; 2009 Apr; 81(7):2779-84. PubMed ID: 19281170 [TBL] [Abstract][Full Text] [Related]
33. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Horger M; Bares R Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146 [TBL] [Abstract][Full Text] [Related]